Insider · CIK 0001730615

Violin Jonathan

Reports to the SEC for 6 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001730615

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,050
2026-05-21	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+6,090 sh	—	—	6,090
2026-01-23	ATXSAstria Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−263K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	+14.2K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	+8,333 sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	+14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	+14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	+26.6K sh	—	—	0
2025-06-23	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+9,023 sh	—	—	9,023
2025-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,550
2025-05-22	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-06-05	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2024-05-23	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2023-09-11	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2023-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2023-02-02	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−50K sh	$36.80	−$1.84M	430,905
2023-02-02	VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	$0.15	+$7,500	530,905
2023-02-02	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−50K sh	$36.80	−$1.84M	480,905
2023-02-02	VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	239,205
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-06-01	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−30K sh	$12.20	−$366K	480,905
2022-05-02	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−30K sh	$13.04	−$391K	510,905
2022-04-04	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−3,600 sh	$18.93	−$68.1K	540,905
2022-04-01	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−26.4K sh	$18.92	−$499K	544,505
2022-03-02	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−11.1K sh	$17.36	−$193K	570,905
2022-03-01	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−18.9K sh	$17.82	−$337K	582,011
2022-02-03	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−909 sh	$19.16	−$17.4K	600,905
2022-02-02	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−12.3K sh	$18.47	−$228K	601,814
2022-02-02	VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+280K sh	—	—	280,000
2022-02-01	VRDNViridian Therapeutics, Inc.\DES Sale	Director, Chief Executive Officer	SSale	−16.8K sh	$19.55	−$327K	614,154
2021-12-08	VRDNViridian Therapeutics, Inc.\DEC Conversion	Director, Chief Executive Officer	CConversion	+628K sh	—	—	630,905
2021-12-08	VRDNViridian Therapeutics, Inc.\DE · Series A Non-Voting Convertible Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−9,413 sh	—	—	0
2021-09-20	ATXSAstria Therapeutics, Inc.J Other	Director	JOther	−263K sh	—	—	0
2021-09-20	ATXSAstria Therapeutics, Inc.J Other	Director	JOther	+263K sh	—	—	263,321
2021-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+85K sh	—	—	85,000
2021-01-28	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-01-18	VRDNViridian Therapeutics, Inc.\DE · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+800K sh	—	—	800,075
2020-10-27	VRDNViridian Therapeutics, Inc.\DEJ Other	Director, Chief Executive Officer	JOther	+50.1K sh	—	—	50,124
2020-10-27	VRDNViridian Therapeutics, Inc.\DE · Employee Stock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	+4.34M sh	—	—	4,338,079
2020-10-27	VRDNViridian Therapeutics, Inc.\DE · Series A Non-Voting Convertible Preferred StockJ Other	Director, Chief Executive Officer	JOther	+9,413 sh	—	—	9,413
2018-02-28	TREVENA INCEmployee Stock Option (Right to Buy)A Award	SVP-Scientific Affairs & IR	AAward	+75K sh	—	—	75,000
2018-02-28	TREVENA INCEmployee Stock Option (Right to Buy)A Award	SVP-Scientific Affairs & IR	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
Jun 34
Violin Jonathan0001628280-26-040583
SEC(opens sec.gov)
May 224
Violin Jonathan0001730615-26-000003
SEC(opens sec.gov)
Jan 234
Violin Jonathan0000905148-26-000324
SEC(opens sec.gov)
Jun 234
Violin Jonathan0001104659-25-061818
SEC(opens sec.gov)
Jun 124
Violin Jonathan0001104659-25-059031
SEC(opens sec.gov)
May 224
Violin Jonathan0000950170-25-076412
SEC(opens sec.gov)
Jun 64
Violin Jonathan0001104659-24-069074
SEC(opens sec.gov)
May 284
Violin Jonathan0000950170-24-065560
SEC(opens sec.gov)
Sep 134
Violin Jonathan0000899243-23-018869
SEC(opens sec.gov)
Jun 64
Violin Jonathan0001104659-23-068340
SEC(opens sec.gov)
Feb 74/A
Violin Jonathan0000899243-23-004233
SEC(opens sec.gov)
Feb 34
Violin Jonathan0000899243-23-003921
SEC(opens sec.gov)
Jun 214/A
Violin Jonathan0001104659-22-072752
SEC(opens sec.gov)

Companies

Address

C/O KORSANA BIOSCIENCES, INC. 203 CRESCENT STREET, SUITE 503

WALTHAM, MA, 02453